IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 149 filers reported holding IMMUNOVANT INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $24,736,366 | -39.9% | 644,344 | -27.7% | 0.66% | -24.1% |
Q4 2020 | $41,155,000 | +57.5% | 891,000 | +20.0% | 0.87% | +31.7% |
Q3 2020 | $26,127,000 | +137.2% | 742,449 | +64.1% | 0.66% | +119.5% |
Q2 2020 | $11,014,000 | +183.1% | 452,319 | +80.9% | 0.30% | +87.6% |
Q1 2020 | $3,891,000 | – | 250,000 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |